The Department of Justice has sued OhioHealth and NewYork-Presbyterian Hospital over contracting tactics that allegedly limit competition and keep healthcare prices high. The cases center on “all-or-nothing” contracting practices used to shape insurance networks and influence patient access. The DOJ actions fit into a broader regulator push to scrutinize how health systems structure payer contracts, with potential downstream effects for provider network negotiations and reimbursement dynamics. For biopharma and healthcare stakeholders, aggressive enforcement can change the commercial behavior of large systems, affecting formularies, channel strategy, and the economics of care delivery.